Meeting
2012 Genitourinary Cancers Symposium
Use of elevated baseline IL-8, CCL-2, and TNFα to predict for shorter overall survival (OS) in men with metastatic prostate cancer initiating androgen-deprivation therapy (ADT).
Authors
Jaya Sharma
Dana-Farber Cancer Institute, Boston, MA
Jaya Sharma , Kathryn P. Gray , Mari Nakabayashi , Gillian Petrozziello , Carolyn Evan , Raina Fichorova , Philip W. Kantoff , Christopher Sweeney
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 13)
DOI
10.1200/jco.2012.30.5_suppl.13
Abstract #
13
Poster Bd #
A7
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Microenvironment and cytokines in pseudomyxoma peritonei.
First Author: Kush Lohani
Poster
2023 ASCO Annual Meeting
Whole-food plant-based diet (WFPBD) to control weight and metabo-inflammation in overweight/obese men with prostate cancer (PC) receiving androgen deprivation therapy (ADT): A multi-center randomized control trial.
First Author: Nicole Jacobs
Poster
2023 ASCO Annual Meeting
Effects of yoga vs placebo on inflammation among cancer survivors: A nationwide multicenter phase III randomized controlled trial (RCT).
First Author: Po-Ju Lin
Poster
2023 ASCO Genitourinary Cancers Symposium
A study to determine enzalutamide long term safety and efficacy for men with castration-resistant prostate cancer: A multicenter, prospective DELC study.
First Author: Koji Hatano